LMNB1 and breast cancer: Overexpression of LMNB1 indicates lower survival rates both in pancreatic cancer and colon cancer (Li et al., 2013; Izdebska et al., 2018), while upregulation of LMNB1 represents good clinical outcome in breast cancer (Wazir et al., 2013).